Epidermal growth factor protects against myocardial ischaemia reperfusion injury through activating Nrf2 signalling pathway

References

• Buja LM. Myocardial ischemia and reperfusion injury. Cardiovascular Pathol. 2005;14:170–175.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46:1650–1667.
   PubMed Web of Science ®Google Scholar
• Li W, Wu M, Tang L, et al. Novel curcumin analogue 14p protects against myocardial ischemia reperfusion injury through Nrf2-activating anti-oxidative activity. Toxicol Appl Pharmacol.2015;282:175–183.
   PubMed Web of Science ®Google Scholar
• White SK, Frohlich GM, Sado DM, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2015;8:178–188.
   PubMed Web of Science ®Google Scholar
• Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121–1135..
   PubMed Web of Science ®Google Scholar
• Marczin N, El-Habashi N, Hoare GS, et al. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys. 2003;420:222–236.
   PubMed Web of Science ®Google Scholar
• Xu D, Chen L, Chen X, et al. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO − 1 pathway enhanced autophagy. Cell Death Dis. 2017;8:e2983.
   PubMed Web of Science ®Google Scholar
• Korge P, Calmettes G, Weiss JN. Increased reactive oxygen species production during reductive stress: the roles of mitochondrial glutathione and thioredoxin reductases. Biochim Biophys Acta. 2015;1847:514–525.
   PubMed Web of Science ®Google Scholar
• Nistri S, Boccalini G, Bencini A, et al. A new low molecular weight, MnII-containing scavenger of superoxide anion protects cardiac muscle cells from hypoxia/reoxygenation injury. Free Radic Res. 2015;49:67–77.
   PubMed Web of Science ®Google Scholar
• Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev. 2009;61:290–302.
   PubMed Web of Science ®Google Scholar
• Khanbanha N, Atyabi F, Taheri A, et al. Healing efficacy of an EGF impregnated triple gel based wound dressing: in vitro and in vivo studies. BioMed Res Int. 2014;2014:1–10.
   Google Scholar
• Choi SM, Lee KM, Kim HJ, et al. Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice. Acta Biomater. 2018;66:325–334.
   PubMed Web of Science ®Google Scholar
• Basal O, Atay T, Ciris İM, et al. Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH). Bosnian J Basic Med Sci. 2018;18:352–360.
   Google Scholar
• Yang Y, Duan W, Lin Y, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med. 2013;65:667–679.
   PubMed Web of Science ®Google Scholar
• Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47:1304–1309.
   PubMed Web of Science ®Google Scholar
• Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol. 2011;85:241–272.
   PubMed Web of Science ®Google Scholar
• Ray PS, Maulik G, Cordis GA, et al. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med. 1999;27:160–169.
   PubMed Web of Science ®Google Scholar
• Hung LM, Su MJ, Chu WK, et al. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol. 2002;135:1627–1633.
   PubMed Web of Science ®Google Scholar
• Tipoe G, Leung TM, Hung MW, et al. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007;7:135–144.
   PubMedGoogle Scholar
• Calvert JW, Jha S, Gundewar S, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009;105:365–374.
   PubMed Web of Science ®Google Scholar
• Wang ZH, Liu JL, Wu L, et al. Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusion. Cell Death Dis. 2014;5:e1297.
   PubMed Web of Science ®Google Scholar
• Wang Z, Su G, Zhang Z, et al. 25-Hydroxyl-protopanaxatriol protects against H2O2-induced H9c2 cardiomyocytes injury via PI3K/Akt pathway and apoptotic protein down-regulation. Biomed Pharmacother. 2018;99:33–42.
   PubMed Web of Science ®Google Scholar
• Liu XR, Li T, Cao L, et al. Dexmedetomidine attenuates H2O2-induced neonatal rat cardiomyocytes apoptosis through mitochondria- and ER-medicated oxidative stress pathways. Mol Med Rep. 2018;17:7258–7264.
   PubMed Web of Science ®Google Scholar
• Kim JM, Choung S, Joung KH, et al. Serum soluble epidermal growth factor receptor level increase in patients newly diagnosed with type 2 diabetes mellitus. Diabetes Metab J. 2018;42:343–347.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Overstreet JM, Chung S, et al. Inhibition of epidermal growth factor receptor activation is associated with improved diabetic nephropathy and insulin resistance in Type 2 diabetes. Diabetes. 2018;67:1847–1857.
   PubMed Web of Science ®Google Scholar
• Song Z, Fusco J, Zimmerman R, et al. Epidermal growth factor receptor signaling regulates beta cell proliferation in adult mice. J Biol Chem. 2016;291:22630–22637.
   PubMed Web of Science ®Google Scholar
• Liang D, Zhong P, Hu J, et al. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model. J Mol Cell Cardiol. 2015;82:63–74.
   PubMed Web of Science ®Google Scholar
• Zou C, Li W, Pan Y, et al. 11beta-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity. Oncotarget. 2017;8:96263–96275.
   PubMedGoogle Scholar
• Liu L, Jin X, Hu CF, et al. Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway. Basic Res Cardiol. 2018;113:12.
   PubMed Web of Science ®Google Scholar
• Li W, Fang Q, Zhong P, et al. EGFR Inhibition Blocks palmitic acid-induced inflammation in cardiomyocytes and Prevents hyperlipidemia-induced Cardiac Injury in Mice. Sci Rep. 2016;6:24580.
   PubMed Web of Science ®Google Scholar
• Peng K, Tian X, Qian Y, et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II. J Cell Mol Med. 2016;20:482–494.
   PubMed Web of Science ®Google Scholar
• Lorita J, Soley M, Ramírez I. Epidermal growth factor protects the heart against low-flow ischemia-induced injury. J Physiol Biochem. 2010;66:55–62.
   PubMed Web of Science ®Google Scholar
• Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev. 2007;12:181–188.
   PubMed Web of Science ®Google Scholar
• Benter IF, Juggi JS, Khan I, et al. Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor. Mol Cell Biochem. 2005;268:175–183.
   PubMed Web of Science ®Google Scholar
• Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7:153–163.
   PubMedGoogle Scholar